The Journal of Urology
Volume 181, Issue 6 , Pages 2424-2429 , June 2009

Effects of Obesity and Weight Loss in Patients With Nononcological Urological Disease

  • Vivek Natarajan

      Affiliations

    • Corresponding Author InformationCorrespondence: The Emory Clinic, Department of Urology, 1365 Clifton Rd., Suite B, Atlanta, Georgia 30322 (telephone: 404-778-3038; FAX: 404-778-4006)
    • Nothing to disclose.
    • ,
  • Viraj Master

      Affiliations

    • Nothing to disclose.
    • ,
  • Kenneth Ogan

      Affiliations

    • Financial interest and/or other relationship with Cook Urological.

Received 29 August 2008

References 

  1. Obesity: preventing and managing the global epidemic (Report of a WHO consultation). In: World Health Organization Technical Report Series, 894. Geneva: World Health Organization; 2007;p. i–xii
  2. CDC. Behavioral Risk Factor Surveillance System. www.cdc.gov/brfssAccessed January 19, 2009
  3. Mydlo JH. The impact of obesity in urology. Urol Clin North Am. 2004;31:275
  4. Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low AK, Land KK. The effect of obesity surgery on obesity comorbidity. Am J Med Sci. 2006;331:183
  5. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905
  6. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455
  7. Siener R, Glatz S, Nicolay C, Hesse A. The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004;12:106
  8. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825
  9. Yun SJ, Ha Y-S, Kim TH, Kim Y-J, Lee S-C, Kim WJ. Obesity and phosphaturia as the important predictors for recurrence in first-time urinary stone formers. J Urol. 2007;177(suppl):452;abstract 1369
  10. Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004;172:159
  11. American Society for Metabolic and Bariatric Surgery. www.asbs.orgAccessed January 19, 2009
  12. Palomar R, Fernandez-Fresnedo G, Dominguez-Diez A, Lopez-Deogracias M, Olmedo F, Martin de Francisco AL, et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg. 2005;15:794
  13. Pedro RN, Duffey B, Weiland D, Melquist J, Kriedberg C, Ikramuddin S, et al. Impact of bariatric surgery on urinary stone risk factors in the morbidly obese. J Urol. 2007;177(suppl):451;abstract 1367
  14. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565
  15. Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72:100
  16. Leitao VA, Mutafyan G, Haleblian GE, Robinson MR, Pierre SA, Pryor A, et al. Correlation between stone formation and weight loss after Roux-en-Y gastric bypass. J Urol. 2007;177(suppl):450;abstract 1366
  17. Larsen SH, Wagner G, Heitmann BL. Sexual function and obesity. Int J Obes. 2007;31:1189
  18. Muller A, Mulhall JP. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol. 2006;16:435
  19. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176:217
  20. Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A, et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol. 2006;50:595
  21. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6:1
  22. Liu PY, Wishart SM, Celermajer DS, Jimenez M, Pierro ID, Conway AJ, et al. Do reproductive hormones modify insulin sensitivity and metabolism in older men? (A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin). Eur J Endocrinol. 2003;148:55
  23. Chen RYT, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab. 2006;8:429
  24. Kolotkin RL, Binks M, Crosby RD, Ostbye T, Gress RE, Adams TD. Obesity and sexual quality of life. Obesity. 2006;14:472
  25. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978
  26. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urology. 2000;56:302
  27. Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg. 2001;11:455
  28. Kim KK, Kang HC, Kim SS, Youn BB. Influence of weight reduction by sibutramine on female sexual function. Int J Obes. 2006;30:758
  29. Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity. 2006;14:172
  30. Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562
  31. Xie L-P, Bai Y, Zhang X-Z, Zheng X-Y, Yao K-S, Xu L, et al. Obesity and benign prostatic enlargement: a large observational study in China. Urology. 2007;69:680
  32. Tikkinen KA, Auvinen A, Huhtala H, Tammela TLJ. Nocturia and obesity: a population-based study in Finland. Am J Epidemiol. 2006;163:1003
  33. Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Int Med. 1997;241:71
  34. McGrother CW, Donaldson MMK, Hayward T, Matthews R, Dallosso HM, Hyde C, et al. Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women. Age Ageing. 2006;35:16
  35. Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174:190
  36. Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001;81:1063
  37. Bump RC, Sugerman HJ, Fantl JA, McClish DK. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol. 1992;167:392
  38. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol. 2007;177:1395
  39. U.S. Department of Health and Human Service USDoA. Dietary Guidelines for Americans. 6th ed.. Washington, D. C: Government Printing Office; 2005;
  40. Carels RA, Young KM, Coit C, Clayton AM, Spencer A, Hobbs M. Can following the caloric restriction recommendations from the Dietary Guidelines for Americans help individuals lose weight?. Eat Behav. 2008;9:328
  41. Hollis JF, Gullion CM, Stevens VJ, Brantley PJ, Appel LJ, Ard JD, et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med. 2008;35:118

 Editor's Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 2834 and 2835.

PII: S0022-5347(09)00277-8

doi: 10.1016/j.juro.2009.01.107

The Journal of Urology
Volume 181, Issue 6 , Pages 2424-2429 , June 2009

Article Tools